Accuracy of axillary staging using sentinel node biopsy of diagnostic axillary lymph node dissection - A case-control study

APMIS

Volumn 112, Issue 4-5, 2004, Pages 264-270

  Leidenius, Marjut ^a   Krogerus, Leena ^b   Tukiainen, Eija ^a   Von Smitten, Karl ^a  

^a Maria Hospital   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Axillary lymph node dissection; Axillary staging; Breast cancer; Lymph node metastases; Sentinel node biopsy

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; INVASIVE CARCINOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SENTINEL LYMPH NODE BIOPSY;

EID: 3442877042     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2004.apm11204-0506.x     Document Type: Article

References (27)

1. Morrow M, Foster RS. Staging of breast cancer. A new rationale for internal mammary node biopsy. Arch Surg 1981;166:748-51.
2. Noguchi M, Ohta N, Kioyasaki N, Taniya T, Miyazaki I, Mizukami Y. Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer. Cancer 1991;68: 1918-25.
3. Veronesi U, Cascinelli N, Greco M, Bufalino R, Morabito A, Galluzo D, et al. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg 1985; 202:702-7.
4. Barth A, Craig P, Silverstein M. Predictors of axillary lymph node metastases in patients with Tl breast carcinoma. Cancer 1997;79:1918-22.
5. Rivadneira DE, Simmons RM, Christos PJ, Hanna K, Daly JM, Osborne MP. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients. J Am Coll Surg 2000;191:1-6.
6. Silverstein M, Skinner KA, Lomis TJ. Predicting axillary nodal positivity in 2282 patients with breast carcinoma. World J Surg 2001;25:767-72.
7. Brenin DR, Manasseh D-M, El-Tamer M, Troxel A, Schnabel F, Ditkoff BA, et al. Factors correlating with lymph node metastases in patients with T1 breast cancer. Ann Surg Oncol 2001;8: 432-7.
8. Martin C, Cutuli B, Velten M. Predictive model of axillary lymph node involvement in women with small invasive breast carcinoma. Cancer 2002;94:314-22.
9. Bevilacqua JLB, Cody HS, MacDonald KA, Tan LK, Borgen PI, Van Zee KJ. A model for predicting axillary node metastases based on 2000 sentinel node procedures and tumour position. Eur J Surg Oncol 2002;28:490-500.
10. Miltenburg DM, Miller C, Karamlou TB, Brunicardi FC. Meta-analysis of sentinel lymph node biopsy in breast cancer. J Surg Res 1999;84:138-42.
11. Fentiman IS, Mansel RE. The sentinel node negative axilla: is it a no-go zone? Cancer Treat Rev 2002;28:1-3.
12. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995;222:394-401.
13. th ed. New York: Wiley, 2002:131-41.
14. Bloom HJG, Richardson WW. Histological grading and prognosis of breast cancer. A study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 1957;XI:359-77.
15. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of hiostological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991;19:403-10.
16. Moonka R, Hunter JA, Cray Jr WK, Duncan M, Wechter DG. A comparison of rates of axillary node metastases between patients undergoing sentinel node biopsy and sentinel lymphadenectomy. Am J Surg 2002;183:558-61.
17. Schrenk P, Shamiyeh A, Wayand W. Sentinel lymph-node biopsy compared to axillary lymph-node dissection for axillary staging in breast cancer patients. Eur J Surg Oncol 2001;27:378-82.
18. Noguchi M. Sentinel node biopsy and breast cancer. Br J Surg 2002;89:21-34.
19. Bussolati G, Gugliotta P, Morra I, Pietribiasi F, Berardengo E. The immunohistochemical detection of lymph node metastases from infiltrating lobular carcinoma of the breast. Br J Cancer 1996;54:631-6.
20. Papadatos G, Rangan AM, Psarianos T, Ung O, Taylor R, Boyages J. Probability of axillary node involvement in patients with tubular carcinoma of the breast. Br J Surg 2001;88:860-4.
21. Wong SL, Chao C, Edwards MJ, Carlson DJ, Laidley A, et al. Frequency of sentinel lymph node metastases in patients with favourable breast cancer histologic subtypes. Am J Surg 2002;184:492-8.
22. Widt-Levert LM, Tjan-Heinen VCG, Bult P, Ruers TJ, Wobbes T. Stage migration in breast cancer: surgical decisions concerning isolated tumour cells and micro-metastases in sentinel lymph node. Eur J Surg Oncol 2003;29:216-20.
23. Maiorano E, Mazzarol GM, Pruneri G, Mastropasqua MG, Zurrida S, Orvieto E, et al. Ectopic breast tissue as possible cause of false-positive axillary sentinel lymph node biopsies. Am J Surg Pathol 2003;27:513-8.
24. Tamhane R, Dahlström JE, McCallum DD, Buckingham JM. The clinical significance of cytokeratin-positive cells in lymph nodes at the time of mastectomy from patients with ductal carcinoma-in-situ. Ann Surg Oncol 2002;9:999-1003.
25. Maibenco DC, Weiss LK, Pawlish KS, Severson RK. Axillary lymph node metastases associated with small invasive carcinoma. Cancer 1999;85: 1530-6.
26. Benson JR. Overview of the TNM system. Lancet Oncol 2003;4:56-7.
27. European Commission Working Group on Breast Screening Pathology. Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas. Virchows Arch 1999;434: 3-10.